in

Browse by Tags

  • Sign of things to come?

    The big news today is Daiichi Sankyo's acquisition of a controlling stake in Ranbaxy , India's largest pharmaceutical company, for $4.6bn. Analysts have been quick to predict many more such deals which will see international pharma majors entering the generic space. Indian generic players have...
    Posted to ICIS Blogs (Weblog) by Anonymous on 06-12-2008
  • Testing times for CRAMS

    Business is booming in India’s custom research and manufacturing services (CRAMS) industry thanks to the country's strong process chemistry skills, low operational costs and the availability of a skilled workforce. Frost & Sullivan values the Indian CRAMS market at $890m, and expects it to expand...
    Posted to ICIS Blogs (Weblog) by Anonymous on 02-11-2008
Page 1 of 1 (2 items)
© RBI 2008
Powered by Community Server (Commercial Edition), by Telligent Systems